0000899243-22-004134.txt : 20220202
0000899243-22-004134.hdr.sgml : 20220202
20220202160553
ACCESSION NUMBER: 0000899243-22-004134
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220131
FILED AS OF DATE: 20220202
DATE AS OF CHANGE: 20220202
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WILKERSON L JOHN
CENTRAL INDEX KEY: 0000923421
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36415
FILM NUMBER: 22583628
MAIL ADDRESS:
STREET 1: C/O GALEN ASSOCIATES
STREET 2: 610 FIFTH AVENUE 5TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10020
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Quotient Ltd
CENTRAL INDEX KEY: 0001596946
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 264719797
STATE OF INCORPORATION: Y9
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 28 ESPLANADE
CITY: SAINT HELIER
STATE: Y9
ZIP: JE2 3QA
BUSINESS PHONE: 41274832286
MAIL ADDRESS:
STREET 1: 28 ESPLANADE
CITY: SAINT HELIER
STATE: Y9
ZIP: JE2 3QA
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-01-31
0
0001596946
Quotient Ltd
QTNT
0000923421
WILKERSON L JOHN
C/O GALEN PARTNERS,
680 WASHINGTON BLVD
STAMFORD
CT
06901
1
0
0
0
Ordinary Shares
7329074
I
See Footnote
Ordinary Shares
2022-01-31
4
M
0
11660
A
83298
D
Ordinary Shares Option (Right to buy)
11.62
2025-10-31
Ordinary Shares
7505
7505
D
Ordinary Shares Option (Right to buy)
8.00
2024-04-29
Ordinary Shares
3500
3500
D
Ordinary Shares Option (Right to buy)
9.95
2024-10-31
Ordinary Shares
5025
5025
D
Ordinary Shares Option (Right to buy)
5.73
2026-10-31
Ordinary Shares
8726
8726
D
Ordinary Shares Option (Right to buy)
5.21
2027-10-31
Ordinary Shares
9597
9597
D
Ordinary Shares Option (Right to buy)
6.41
2028-10-31
Ordinary Shares
6240
6240
D
Ordinary Shares Option (Right to buy)
7.78
2029-10-31
Ordinary Shares
8158
8158
D
Ordinary Share Option (Right to Buy)
4.55
2030-10-31
Ordinary Shares
13611
13611
D
Restricted Stock Units
2022-01-31
4
M
0
10870
0.00
D
Ordinary Shares
10870
32608
D
Restricted Stock Units
2022-01-31
4
M
0
790
0.00
D
Ordinary Shares
790
2372
D
Ordinary Share Option (Right to Buy)
2.53
2031-10-31
Ordinary Shares
24040
24040
D
Restricted Stock Units convert into ordinary shares on a one-for-one basis.
Includes 6,613,590 ordinary shares held of record by Galen V, 564,780 ordinary shares held by Galen International V, and 150,704 ordinary shares held of record by Galen Management, LLC. Mr. Wilkersonis a managing director of Galen Management, LLC, and shares voting and dispositive power over the securities held by Galen V, Galen International V and Galen Management, LLC. The Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of his pecuniary interest therein.
All 7,505 options have vested and remain exercisable.
All 3,500 options have vested and remain exercisable.
All 5,025 options have vested and remain exercisable.
All 8,726 options have vested and remain exercisable.
All 9,597 options have vested and remain exercisable.
All 6,240 options have vested and remain exercisable.
2,719 options vested on October 31, 2021 and remain exercisable, and the remaining 2,270 options will vest on October 31, 2022.
All 13,611 options have vested and remain exercisable.
On October 31, 2021, the Reporting Person was granted 43,478 restricted stock units, of which 10,870 have vested and have converted into ordinary shares. The remaining 32,608 restricted stock units will vest in three equal installments on April 30, 2022, July 31, 2022 and October 31, 2022.
On October 31, 2021, the Reporting Person was granted 3,162 restricted stock units, of which 790 have vested and have converted into ordinary shares. The remaining 2,372 restricted stock units will vest in three equal installments on April 30, 2022, July 31, 2022 and October 31, 2022.
The options vest and become exercisable on October 31, 2022.
/s/ L. John Wilkerson
2022-02-02